In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Calciptriol, MC-903, Daivonex, Dovonex, Psorcutan Drug Master File in Korea (Calciptriol, MC-903, Daivonex, Dovonex, Psorcutan KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Calciptriol, MC-903, Daivonex, Dovonex, Psorcutan. The MFDS reviews the Calciptriol, MC-903, Daivonex, Dovonex, Psorcutan KDMF as part of the drug registration process and uses the information provided in the Calciptriol, MC-903, Daivonex, Dovonex, Psorcutan KDMF to evaluate the safety and efficacy of the drug.
After submitting a Calciptriol, MC-903, Daivonex, Dovonex, Psorcutan KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Calciptriol, MC-903, Daivonex, Dovonex, Psorcutan API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Calciptriol, MC-903, Daivonex, Dovonex, Psorcutan suppliers with KDMF on PharmaCompass.